ES2368089T3 - Derivados de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2-metilaminoquinazolina. - Google Patents

Derivados de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2-metilaminoquinazolina. Download PDF

Info

Publication number
ES2368089T3
ES2368089T3 ES07714569T ES07714569T ES2368089T3 ES 2368089 T3 ES2368089 T3 ES 2368089T3 ES 07714569 T ES07714569 T ES 07714569T ES 07714569 T ES07714569 T ES 07714569T ES 2368089 T3 ES2368089 T3 ES 2368089T3
Authority
ES
Spain
Prior art keywords
compound
salt
hydrate
dimethoxy
methylaminoquinazolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07714569T
Other languages
English (en)
Spanish (es)
Inventor
Kazuki Miyazaki
Kazutomi Kusano
Yasutaka Takase
Osamu Asano
Manabu Shirato
Hisashi Wakita
Naoto Ishii
Takao Saeki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Application granted granted Critical
Publication of ES2368089T3 publication Critical patent/ES2368089T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES07714569T 2006-02-21 2007-02-20 Derivados de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2-metilaminoquinazolina. Active ES2368089T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006043273 2006-02-21
JP2006043273 2006-02-21

Publications (1)

Publication Number Publication Date
ES2368089T3 true ES2368089T3 (es) 2011-11-14

Family

ID=42137992

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07714569T Active ES2368089T3 (es) 2006-02-21 2007-02-20 Derivados de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2-metilaminoquinazolina.

Country Status (18)

Country Link
JP (1) JP4778550B2 (ko)
KR (1) KR101278852B1 (ko)
AT (1) ATE517875T1 (ko)
BR (1) BRPI0708098B8 (ko)
CY (1) CY1112554T1 (ko)
DK (1) DK1992622T3 (ko)
ES (1) ES2368089T3 (ko)
HK (1) HK1122025A1 (ko)
HR (1) HRP20110604T1 (ko)
IL (1) IL193322A (ko)
JO (1) JO2726B1 (ko)
MY (1) MY146275A (ko)
NZ (1) NZ569936A (ko)
PT (1) PT1992622E (ko)
RS (1) RS51969B (ko)
RU (1) RU2431632C2 (ko)
SI (1) SI1992622T1 (ko)
TW (1) TWI404709B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2123641A4 (en) 2007-02-16 2011-06-22 Eisai R&D Man Co Ltd CRYSTAL, AMORPHOUS FORM AND METHYL N-Ý3- (6,7-DIMETHOXY-2-METHYLAMINOQUINAZOLINE-4-YL) PHENYLENE TEREPHTALIC ACID SALT
AU2008290000B2 (en) 2007-08-17 2012-05-10 Eisai R & D Management Co., Ltd. Method for producing quinazoline derivative
TWI414296B (zh) 2007-08-17 2013-11-11 Eisai R&D Man Co Ltd Innovative agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬

Also Published As

Publication number Publication date
HK1122025A1 (ko) 2009-05-08
JO2726B1 (en) 2013-09-15
NZ569936A (en) 2010-07-30
MY146275A (en) 2012-07-31
BRPI0708098B8 (pt) 2021-05-25
RU2431632C2 (ru) 2011-10-20
KR101278852B1 (ko) 2013-07-01
TW200812980A (en) 2008-03-16
SI1992622T1 (sl) 2011-11-30
PT1992622E (pt) 2011-09-19
JP4778550B2 (ja) 2011-09-21
IL193322A (en) 2014-04-30
TWI404709B (zh) 2013-08-11
CY1112554T1 (el) 2016-02-10
DK1992622T3 (da) 2011-09-05
KR20080094811A (ko) 2008-10-24
BRPI0708098A2 (pt) 2011-05-17
BRPI0708098B1 (pt) 2019-08-06
RS51969B (en) 2012-02-29
JPWO2007097317A1 (ja) 2009-07-16
HRP20110604T1 (hr) 2011-09-30
RU2008137654A (ru) 2010-03-27
ATE517875T1 (de) 2011-08-15
IL193322A0 (en) 2009-05-04

Similar Documents

Publication Publication Date Title
US11485726B2 (en) Compound for inhibiting and degrading tyrosine protein kinase ALK
JP5596139B2 (ja) 二置換フタラジンヘッジホッグ経路アンタゴニスト
WO2021190467A1 (zh) 含螺环的喹唑啉化合物
JP4405602B2 (ja) ヒストン脱アセチル化酵素阻害剤
ES2528796T3 (es) Benzo[c]fenantridinas pseudobásicas con eficacia, estabilidad y seguridad mejoradas
AU2009241561B2 (en) Disubstituted phthalazine hedgehog pathway antagonists
WO2021027911A1 (zh) 新型螺环类K-Ras G12C抑制剂
EP1992622B1 (en) 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
CN112300153B (zh) 一种杂环化合物、药物组合物和用途
CN113024544B (zh) 一种含氰基并杂环化合物及其用途
US9981946B2 (en) Pyridine-substituted 2-aminopyridine protein kinase inhibitors
ES2958528T3 (es) Macrociclos sustituidos útiles como inhibidores de quinasas
AU2008215411B2 (en) Crystal, amorphous form and salt of methyl N-[3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
TW200410695A (en) Quinazolinone derivatives useful as anti-hyperalgesic agents
JP5404607B2 (ja) 抗rnaウイルス作用を有するアニリン誘導体
ES2368089T3 (es) Derivados de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2-metilaminoquinazolina.
An et al. Inhibition of TGF-β1/Smad3 signaling by compound 5aa: A potential treatment for idiopathic pulmonary fibrosis
CN115028648B (zh) 三并环化合物及其药物组合物和应用
WO2023168740A1 (zh) 喹啉类化合物的新用途
WO2023206655A1 (zh) 一种PI3Kδ抑制剂及其用途
JP5102230B2 (ja) メチルn−[3−(6,7−ジメトキシ−2−メチルアミノキナゾリン−4−イル)フェニル]テレフタラミックアシッドの結晶、非晶質体または塩
CN118772107A (zh) Hdac抑制剂及其用途
KR20090118025A (ko) 메틸 n-[3-(6,7-디메톡시-2-메틸아미노퀴나졸린-4-일)페닐]테레프탈람산의 결정, 비정질체 또는 염